Hormone Therapy News

Men prescribed long-acting testosterone undecanoate injections had a higher adherence to therapy at 1 year compared with those receiving short-acting testosterone cypionate injections, according to study findings.

Black adults undergoing gender-affirming surgery have higher odds for reoperation, 30-day readmission and organ/space surgical site infection than white patients, according to study data published in LGBT Health.

Menopausal hormone therapy remains the most effective treatment for vasomotor symptoms and genitourinary syndrome of menopause, according to an updated position statement from the North American Menopause Society.

Although incidence was low, transgender individuals in Sweden experienced higher CVD incidence compared with cisgender controls from the country’s general population, researchers reported.

Low income, Medicaid insurance and lack of family support were among the factors associated with transgender and nonbinary youths experiencing delays in receiving puberty blockers or gender-affirming hormones, according to study data.

ATLANTA — Adults with overweight or obesity and nonalcoholic fatty liver disease, or NAFLD, had a significant reduction in liver fat and inflammation with daily subcutaneous growth hormone administration, according to a speaker.

ATLANTA — Adults with growth hormone deficiency have higher health care costs and more comorbidities than those without growth hormone deficiency, according to findings presented at ENDO 2022.

A joint statement from three medical organizations advised health care professionals to recognize that women experiencing menopause need individualized treatment options.

Experts from across the field of endocrinology will gather in Atlanta beginning Saturday for the first in-person Endocrine Society annual meeting in 3 years.

In men with hypogonadism, there was no evidence that testosterone treatments cause short-term or medium-term CV risks, according to a meta-analysis published in The Lancet Healthy Longevity.